Identifying the Lipidomic Effects of a Rare Loss-of-Function Deletion in ANGPTL3

BACKGROUND: The identification and understanding of therapeutic targets for atherosclerotic cardiovascular disease (ASCVD) is of fundamental importance given its global health and economic burden. Inhibition of angiopoietin-like 3 (ANGPTL3) has demonstrated a cardioprotective effect, showing promise...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Circ Genom Precis Med
Egile Nagusiak: Blackburn, Nicholas B., Meikle, Peter J., Peralta, Juan M., Kumar, Satish, Leandro, Ana C., Bellinger, Melissa A., Giles, Corey, Huynh, Kevin, Mahaney, Michael C., Göring, Harald H. H., VandeBerg, John L., Williams-Blangero, Sarah, Glahn, David C., Duggirala, Ravindranath, Blangero, John, Michael, Laura F., Curran, Joanne E.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2021
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8206021/
https://ncbi.nlm.nih.gov/pubmed/33887960
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCGEN.120.003232
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak